Natural products, their derivatives and traditional remedies have an uprising attention in drug discovery approaches [1] [2] [3] . Natural products are characterized by their structural diversity so; they could be utilized as biological function modifiers [4, 5] . This open the door for the development of new technologies in discovering new drugs based on natural products' screening, because they are a rich wealth of bioactive compounds [5, 6] . Yet, its poor aqueous solubility, inadequate permeability, and suboptimal bioavailability limited their uses. Therefore, several approaches have been developed to improve solubility, permeability and bioavailability of natural products [7, 8] . Boswellia carterii is a plant native to India, Arabian, Red Sea region of North-East Africa (Somalia, Eritrea) and rich with oleogum resin with various biological activities. Badria., et al. have investigated the various therapeutic applications of Boswellia including anti-inflammatory [9-11], hepatoprotective [12], immunomodulatory [13], anti-ulcer [8], antiviral [14], and other biological activities [15].
Introduction
Natural products emerge as a valuable and affordable source for potential drugs which may be used as lead for treatment of many diseases. Using both in vitro and in vivo models, Badria and his team were able to find different natural products with superb biological activities.Liver fibrosis represents a major health burden and is one of the most common causes of death worldwide. The possible hepatoprotective effect of methanolic extract of Saussurea lappa (Sl) root was investigated against CCl 4 -induced liver fibrosis in rats.
Intraperitoneal injection of 50% CCl 4 (1ml/kg) twice weekly for 8 weeks, significantly raised the levels of serum ALT, AST, liver MDA and percentage of collagen area and significantly decreased liver GSH as compared to the control group fed on basal diet only. Administration of Sl root extract to the rats in a daily dose of 400 mg/kg, concomitantly with CCl 4 , significantly prevented the CCl 4 -induced rise in plasma levels of ALT, AST, liver MDA and percentage of collagen area and increased liver GSH as compared to the CCl 4 -treated group. Moreover, liver histopathology in Sl-treated group showed relatively preserved architecture, less inflammatory cellular infiltration, less collagen deposition with less positive reaction in immunohistochemical staining for α-SMA, as compared to CCl 4 -treated group. These results explained the preventive effect of Sl root extract on liver fibrosis in rats, through antioxidant, anti-inflammatory activities and through prevention of hepatic stellate cell activation. 
Animals and chemicals

Induction of liver fibrosis
According to the OECD-423 guidelines for acute oral toxicity, the LD50 dose of 2000 mg/kg and above for Sl root extract is categorized a sun-classified. 1/5of the LD50, 400mg/kg was taken as dose for the evaluation of antifibrotic activity.
Toxicity issue
Animals were divided into three groups of six rats each. Group 1 (negative control) received basal diet. Group2 (CCl 4 -treated) received intraperitoneal injection of CCl 4 at dose of 1ml/kg dissolved in corn oil at 1:1 ratio twice weekly for 8 weeks. Group 3 (Sl-treated group) received both CCl 4 , as described in group 2, and Sl methanolic root extract via gastric tube in a dose of 400mg/ kg daily for 8 weeks.
Hepatoprotective study
Serum ALT and AST, liver MDA and GSH, percentage of area occupied by collagen tissue were all presented as mean and standard deviation and the mean of two groups were compared by the independent samplet-test. P-value of <0.05 was considered as significant.
Statistical analysis
CCl 4 -induced liver fibrosis in rat is a commonly used model. CCl 3 , the toxic metabolite of CCl 4 , binds to lipoprotein causing lipid peroxidation, Kupffer cell activation and initiation of an inflammatory response [6] . Yaeesh., et al. [2] were the first one to report the hepatoprotective activity of Sl root extract against acute hepatitis induced by injection of d-galactosamine (D-GalN) and lipopolysaccharide in mice. However, the present study differs from that of Yaeesh., et al. [2] in that, the present study evaluated the efficacy of Sl root extract in prevention of chronic liver toxicity induced by CCl 4 in rats, applying different techniques: histopathological, immunohistochemistry and measuring serum liver enzymes and hepatic oxidative stress marker levels.
In our study, Sl-treated group showed significant decrease in serum ALT and AST, Liver MDA and in the area occupied by collagen with significant increase in liver GSH as compared to the CCl 4treated group (Table 1) . Liver histopathology of Sl-treated group showed a decrease in; liver distortion, inflammatory cell infiltration and collagen deposition, with fewer thinner septa and less positive reaction for α-SMAascomparedtotheCCl 4 -treatedgroup (Table   1 , Figure 1 
Results and Discussion
Conclusion
This may result from prevention of HSCs activation by the antioxidant and anti-inflammatory effects of Slor loss of those cells after activation. This loss is probably through apoptosis correlated to the results of Kim., et al. [8] who reported an apoptotic effect of dehydrocostus lactone, extracted from Sl root, against cancer cells.
